What Unipharma does

Unipharma, S.A. is a privately held, family-owned Spanish dermopharmaceutical laboratory founded in 1970 in El Papiol (Barcelona) by Salvador García and currently led by Director Gloria García. The company develops, manufactures and commercializes a portfolio of approximately 30 dermocosmetic and pharmaceutical specialty products organized across eight therapeutic verticals: dermatology, pediatrics, podology, allergology, geriatrics, oncology, maternity and women's health. Its product range includes branded lines such as AVENA (oat-based), DERMIUREA (urea-based at 5%–30% plus facial), PIROTEX DS, TRIETAL ATÓPICO, AVENTAL, CODIGEL and the prescription pharmaceutical specialty SARCOP (permethrin 5% cream for scabies, financed by the Spanish National Health System).

The company's underlying technology and capabilities are rooted in skin-barrier and microbiota-focused formulation under pharmaceutical-grade manufacturing standards. Production takes place in white-room environments compliant with ISO 22716:2007 GMP for cosmetics, with full batch recording, raw materials documentation and process traceability. The firm also holds ISO 9001:2015 (quality), ISO 14001:2015 (environmental) and EU Good Distribution Practice certifications, which together qualify it for regulated pharmaceutical distribution and contract manufacturing.

Unipharma operates three revenue streams. The primary stream is proprietary dermocosmetic and pharmaceutical product sales through Spanish pharmacies, driven by prescription and recommendation from dermatologists, pediatricians, podiatrists, allergists, geriatricians and oncologists. The second stream is pharmaceutical specialty sales, exemplified by SARCOP under SNS reimbursement. The third stream is third-party contract manufacturing (B2B) for cosmetic brands, offering formulation, white-room production, packaging, quality control and traceability from pilot to industrial scale. Internationally, the company has pursued a channel-partner go-to-market since 2007 with consolidated presence across Latin American markets and stated intent to develop further strategic alliances.

Name

Unipharma

Legal name

UNIPHARMA, S.A.

Website

https://unipharma.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Short description

Unipharma is a family-owned Spanish dermopharmaceutical laboratory founded in 1970 that develops and manufactures prescription and over-the-counter skincare products across eight therapeutic verticals, distributing through pharmacies, healthcare professionals, Latin American distributors and third-party contract manufacturing clients.

Ownership category

akta.pro rank

Product category

Dermo-pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermatology Specialty Pharmaceuticals (HLAIACAL)

Keywords

• Dermocosmetic manufacturing
• Pharmaceutical specialties
• Skincare formulations
• Dermatological products
• Contract manufacturing

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Proprietary Dermo-cosmetic Product Sales: Development, production and commercialization of own-brand dermocosmetic and pharmaceutical products distributed through pharmacies and healthcare professionals to end consumers.
2. Third-Party Cosmetic Manufacturing Services: Contract manufacturing services for cosmetic brands including formulation, production in white rooms, conditioning, packaging, and quality control. Flexible production volumes from pilot to industrial scale.
3. Pharmaceutical Specialties: Sales of pharmaceutical specialties including SARCOP (permethrin cream for scabies treatment) financed by Spanish National Health System.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Unipharma develops, manufactures, and commercializes proprietary dermo-cosmetic and pharmaceutical specialty products for skincare, hygiene, and dermatological therapy (e.g., SARCOP®, DERMIUREA®, PIROTEX® DS, TRIETAL® ATÓPICO), distributed through pharmacies and via healthcare professional recommendation in Spain and Latin America. In parallel, the laboratory offers third-party contract manufacturing services ("fabricación a terceros") for cosmetic brands, producing formulations on a white-label basis in its certified clean room facility in El Papiol, Barcelona.

Product overview

Unipharma is a family-owned Spanish pharmaceutical laboratory founded in 1970, specializing in dermopharmacy, dermocosmetics, and pharmaceutical specialties. The company operates with a clinical-therapeutic approach, manufacturing at pharmaceutical standards, and distributing through healthcare professionals, pharmacies, and end consumers. The product portfolio spans two main categories: dermocosmetics organized by therapeutic areas (Dermatology, Pediatrics, Podology, Allergology, Geriatrics, Oncology, Maternity, Women's Health) and pharmaceutical specialties. Key dermocosmetic lines include AVENA (oat-based products), PIROTEX DS (dermatological care), DERMIUREA (urea-based moisturizers at 5%, 10%, 20%, 30%, and facial formulations), TRIETAL ATÓPICO (atopic skin), TAR-PLUS (tar-based treatments), ALMITAL NEO (skin health), CODIGEL (intimate care), and SARCOP as the flagship pharmaceutical specialty (permethrin-based scabies treatment). The company also offers third-party cosmetic manufacturing services from its facilities in El Papiol, Barcelona.

Differentiator

Problem solved

Functional benefit

Products and services

• SARCOP® SARCOP® is a pharmaceutical specialty product from Unipharma indicated for the treatment of scabies, available as a permethrin-based topical formulation. It is a prescription pharmaceutical specialty within the company's dermo-pharmaceutical portfolio, distributed through pharmacies and prescribed by healthcare professionals.
• AVENTAL® AVENTAL® is a calming protective cream for sensitive and reactive skin, formulated within Unipharma's dermo-cosmetic line. It is positioned for adult consumers and patients seeking skin barrier protection and soothing care, and is distributed through pharmacies.
• DERMIUREA® DERMIUREA® is Unipharma's urea-based moisturizer line, available in 5%, 10%, 20%, and 30% concentrations plus a Facial variant, indicated for the treatment of dry, very dry, and xerotic skin. The range targets adult patients and is dispensed through pharmacies for hydration and keratolytic therapy.
• PIROTEX® DS PIROTEX® DS is Unipharma's dermatological line for seborrheic dermatitis and related scalp and skin conditions, available as a cream, shampoo, lotion, emulsion, and soap solution. The line is used by adult and adolescent patients for the control of flaking, irritation, and seborrheic presentations, and is sold through pharmacies.
• TRIETAL® ATÓPICO TRIETAL® ATÓPICO is Unipharma's skincare range formulated for atopic-prone skin, designed to support the skin barrier and reduce irritation in atopic dermatitis patients. It targets infants, children, and adults with atopic skin and is dispensed through pharmacies.
• AVENA AVENA is Unipharma's oat-based dermo-cosmetic line for daily skin hygiene and care, available in bath, body milk, and soap solution formats. It is intended for sensitive skin and is dispensed through pharmacies.
• ALMITAL® NEO ALMITAL® NEO is Unipharma's dermo-cosmetic line for skin care and deodorant use, available in cream and roll-on formats. It is distributed through pharmacies for daily underarm and skin care needs.
• CODIGEL® CODIGEL® is Unipharma's intimate hygiene and hydration line, available in intimate hydrating and intimate soap formats for daily intimate care. The line is targeted at adult women and is distributed through pharmacies.
• TAR-PLUS TAR-PLUS is Unipharma's tar-based dermo-cosmetic range for psoriasis-prone and scaly skin, available as an emollient and soap solution. The line is used by adult patients with scaly, hyperkeratotic skin presentations and is dispensed through pharmacies.
• LACTODERMOL® PH5,5 LACTODERMOL® PH5,5 is Unipharma's maternity and infant care range formulated at physiological pH 5.5 for daily hygiene and skin care of babies and mothers. It is sold through pharmacies for neonatal and sensitive-skin use.
• LACTUM® LACTUM® is Unipharma's maternity care product designed for use during pregnancy and the postpartum period, addressing nipple care and related maternal skin needs. It is distributed through pharmacies for maternal care.
• EMOIL® EMOIL® is Unipharma's emollient dermo-cosmetic line for dry and very dry skin, available as a cream and emollient formulation. It is used by adult and pediatric patients for skin hydration and lipid replenishment and is sold through pharmacies.
• ACON® ACON® is a Unipharma dermo-cosmetic product for skin care, distributed through pharmacies as part of the company's therapeutic skincare portfolio.
• CETRIMIDA® CETRIMIDA® is Unipharma's pediatric antiseptic/antimicrobial hygiene product for infant and child skin care. It is used in pediatric hygiene routines and is distributed through pharmacies.
• DERMOSUL PH5 DERMOSUL PH5 is Unipharma's dermo-cosmetic line for sensitive skin hygiene and care at pH 5, formulated for daily use on reactive and sensitive skin types. It is sold through pharmacies.
• DESULPIR® AZUFRADO DESULPIR® AZUFRADO is Unipharma's sulfur-based dermo-cosmetic product for acne-prone and seborrheic skin, used as an adjunct in the management of acne and oily skin conditions. It is dispensed through pharmacies.
• HIDROMAR® HIDROMAR® is a Unipharma dermo-cosmetic product positioned within the company's skincare portfolio, formulated for daily skin hydration and care, and distributed through pharmacies.
• SILSEN® SILSEN® is Unipharma's pediatric dermatological care product, formulated for the care of infant and child skin conditions, and distributed through pharmacies.
• CUTIDERM® CUTIDERM® is a Unipharma dermo-cosmetic product for skin care, positioned within the company's therapeutic skincare range and distributed through pharmacies.
• Third-Party Cosmetic Manufacturing Services (Fabricación a terceros) Third-Party Cosmetic Manufacturing Services ("fabricación a terceros") is Unipharma's B2B contract manufacturing offering, providing formulation, production, and packaging of dermo-cosmetic and personal-care products on behalf of other cosmetic brands. The service leverages the company's ISO 22716-, ISO 9001-, and ISO 14001-certified facility in El Papiol, Barcelona, with white-room clean-room production and full traceability, and is targeted at cosmetic and personal-care brand clients seeking certified manufacturing capacity.

Segments11 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• IFC Dermatología: Spanish family-owned dermocosmetic laboratory selling through pharmacy and professional channels across therapeutic categories. Closely mirrors Unipharma in size, geography, and channel.
• Bioderma (NAOS): French dermocosmetic brand owned by NAOS, focused on skin-barrier and microbiota concepts through pharmacy distribution. Highly comparable scientific positioning (microbiome, skin barrier) and prescriber-led channel model.
• Martiderm: Spanish dermocosmetic laboratory specializing in ampoule-based skincare distributed through pharmacy channels. Comparable mid-market Spanish dermo-cosmetics peer with similar prescriber-driven distribution model.
• Laboratorios LETI: Spanish family-owned pharmaceutical laboratory specializing in dermatology, allergology, and immunology, distributed via prescription and pharmacy channels. Closely comparable in Spanish footprint, family ownership, and dermo-pharma focus.
• Sesderma: Spanish family-founded dermocosmetic laboratory with similar product portfolio across dermatology, anti-aging, and skin-barrier formulations. Highly comparable in size, channel (pharmacy), and therapeutic positioning versus Unipharma.
• Avène (Pierre Fabre Dermatologie): Pierre Fabre's dermocosmetic flagship brand distributed through pharmacy channels globally, focused on sensitive skin, atopy, and post-treatment care. Direct category peer for Unipharma's TRIETAL atopic and AVENA oat lines.
• Uriage: French dermo-cosmetic brand distributed primarily through pharmacies, with thermal-water-based formulations for sensitive and atopic skin. Highly comparable pharmacy-channel, skin-barrier focus.
• SVR Laboratoires: French dermocosmetic laboratory distributed through pharmacy channels, with strong positioning in sensitive, atopic, and barrier-repair skincare. Comparable mid-sized dermo-cosmetics peer.

Broad incumbents

• Almirall: Spanish publicly-listed pharmaceutical company with a significant dermatology franchise, including prescription products distributed through pharmacy channels. A larger-scale Spanish dermo-pharma reference comparable to Unipharma's specialty business.
• La Roche-Posay (L'Oréal): Global dermocosmetic leader owned by L'Oréal, distributed through pharmacy channels. Competes head-to-head with Unipharma across dermatology, oncology, and sensitive-skin segments at much larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/unipharma_sa
• Facebookfacebook.com/UnipharmaSA
• LinkedInlinkedin.com/company/unipharma-s.a.
• Instagraminstagram.com/laboratorios.unipharma/?hl=es

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unipharma